NEW YORK (GenomeWeb) – Transgenomic said today that it has been awarded a two-year, $1.5 million Small Business Technology Transfer grant from the National Institutes of Health to fund a collaborative project with Dana-Farber Cancer Institute.

Under the grant, the partners will augment the multiplexing capabilities of ICE COLD-PCR technology, which was originally developed at Dana-Farber and is exclusively licensed to Omaha, Nebraska-based Transgenomic.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.